Company-led drug recall: Evicel solutions for sealant. Package of two vials containing Human Fibrinogen and Human Thrombin - Omrix Biopharmaceuticals NV - CLDA (12)A/21


The following section/document has been added/updated Title: Company-led drug recall: Evicel solutions for sealant. Package of two vials containing Human Fibrinogen and Human Thrombin - Omrix Biopharmaceuticals NV - CLDA (12)A/21 Summary Omrix Biopharmaceuticals NV are issuing a precautionary recall as a manufacturing process deviation was detected affecting evicel solutions for sealant batches produced before 25 December 2011.
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your subscriber preferences page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. All other enquiries can be directed to email.support@mhra.gsi.gov.uk. This is an automatically generated email. Please do not reply directly to this notification. This service is provided to you at no charge by the MHRA. Medicines and Healthcare products Regulatory Agency 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ

The following section/document has been added/updated

Title:

Company-led drug recall: Evicel solutions for sealant. Package of two vials containing Human Fibrinogen and Human Thrombin - Omrix Biopharmaceuticals NV - CLDA (12)A/21

Summary

Omrix Biopharmaceuticals NV are issuing a precautionary recall as a manufacturing process deviation was detected affecting evicel solutions for sealant batches produced before 25 December 2011.

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your subscriber preferences page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. All other enquiries can be directed to email.support@mhra.gsi.gov.uk.

This is an automatically generated email. Please do not reply directly to this notification. This service is provided to you at no charge by the MHRA.

Medicines and Healthcare products Regulatory Agency
151 Buckingham Palace Road, Victoria, London, SW1W 9SZ

This email has been sent to Email Address because you are subscribed to the MHRA no topic email channel.